It was as a son, not a healthcare CEO, that I experienced the pain of my mom's “do not resuscitate” order being ignored. Her medical team pushed through the door and subjected her to a full code, against her wishes, the night her heart beat for the last time.
Medicaid regulations require that drug companies charge the state-federal health program for the poor the lowest or “best” price that they negotiate with any other buyer. In theory, the best-price requirement protects taxpayers from price-gouging. But the reality is a little different.
While more Americans have health insurance coverage than ever before, there is still a shortage of venues to obtain the primary and preventive-care services everyone needs.
On any given day, nearly 600,000 people are homeless across America. A large cohort of frequent emergency department users comes from their ranks, and many have prolonged lengths of stay for each hospitalization. Addressing the problem of homelessness is critical to reducing healthcare costs.
As medicine continues to make huge strides with technology as its partner, we often forget that physicians remain at the center of medicine, and patients are at the center of physician practices. This brings us to an old practice that is becoming new again: the house call.
Thirteen years ago, I co-authored an Institute of Medicine report documenting that racial and ethnic minority patients routinely receive lower-quality care than their white counterparts, regardless of income or insurance status.
When embraced, accreditation can drive beneficial operational reform. When treated as a box to check, accreditation loses its power. A recent review of patient-centered medical home literature illustrates this dichotomy.
We face a Medicare crisis. Millions of baby boomers are reaching an age where they depend on the program to meet their healthcare needs. At the same time, the government is still struggling to control healthcare costs. This isn't a new problem, but it is one that we must approach strategically and...
The Oct. 27 deadline for submitting comments on the 340B drug pricing program's proposed federal guidance is fast approaching. Defending against potentially damaging consequences for safety net services is crucial, says Robert G. Riney, COO of Henry Ford Health System.
Americans dealing with advanced illness are at risk of overtreatment and undertreatment because powerful and silent incentives are often driving their healthcare, rather than their own unique values and goals, says Dr. David L. Brown, who recently retired as chairman of the Cleveland Clinic's...
Medical group practices are simultaneously servicing the needs of five generations, and this poses a serious issue for physicians who want to provide individualized care. How do we bridge the gap?
In today's 24/7 media cycle, yesterday's news quickly fades as the press moves on to the next story. But sometimes those forgotten stories leave behind important unresolved issues. That's certainly the case with Ebola.